NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Hakim Moulay Dehbi
University College London - London / United Kingdom
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 1353061
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Hakim Moulay Dehbi's MOST POPULAR ARTICLES
1-)
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trialR Al-Lamee, D Thompson, HM Dehbi, S Sen, K Tang, J Davies, T Keeble, ...The Lancet 391 (10115), 31-40, 20188532018
2-)
Use of the instantaneous wave-free ratio or fractional flow reserve in PCIJE Davies, S Sen, HM Dehbi, R Al-Lamee, R Petraco, SS Nijjer, R Bhindi, ...New England Journal of Medicine 376 (19), 1824-1834, 201710212017
3-)
Instantaneous wave-free ratio versus fractional flow reserve to guide PCIM Götberg, EH Christiansen, IJ Gudmundsdottir, L Sandhall, ...New England Journal of Medicine 376 (19), 1813-1823, 201710192017
4-)
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised …B Seddon, SJ Strauss, J Whelan, M Leahy, PJ Woll, F Cowie, ...The lancet oncology 18 (10), 1397-1410, 20174692017
5-)
Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysisAN Nowbar, M Mielewczik, M Karavassilis, HM Dehbi, MJ Shun-Shin, ...Bmj 348, 20142472014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept